303
Views
9
CrossRef citations to date
0
Altmetric
Review Articles

Emerging topical therapies to treat pigmentary disorders: an evidence-based approach

, , ORCID Icon &
Pages 1931-1937 | Received 12 May 2021, Accepted 06 Jun 2021, Published online: 23 Jun 2021
 

Abstract

Background

Hyperpigmentation disorders are commonly encountered in dermatology clinics. The use of prescription-grade and over-the-counter topical lightening agents has increased in popularity, leading to a substantial growth of research over the past decade.

Objective

We seek to review clinical studies evaluating the use of different Rx-grade and OTC ingredients in treating hyperpigmentation.

Methods and materials

A comprehensive search on PubMed was conducted to identify patient-based evidence on the most common ingredients used as topical lightening agents: arbutin, ascorbic acid, cysteamine, hydroquinone, kojic acid, niacinamide, retinoids, and triple-combination therapy. The topicals were classified as either prescription-grade or over-the-counter.

Results

Varying levels of evidence support the use of topicals in treating hyperpigmentation. There were more clinical trials examining Rx-grade products than OTC products. Mild but tolerated side effects are noted in many of these agents.

Conclusion

Careful monitoring and adjustment of doses will be needed to maximize skin lightening benefits and minimize side effects.

Disclosure statement

The authors have no conflicts of interest to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.